Page 23 of articles about antimicrobial

Goal is to cut colistin sales by 65%. Over the course of the next three to four years, all Member States should reduce the use of colistin in animals at least to a target level of 5 mg colistin/population correction unit (PCU).

In less than two months, antibiotic data for over 1.2m pigs has already been contributed by pig producers to the British pig industry’s new on-line medicine book.

To gain a better understanding of the way in which this new type of colistin resistance spreads, the bacteria were examined at molecular level.

A dedicated Codex task force on AMR chaired by South Korea will take the new work forward.

Every year, 700,000 people die in the world because of antimicrobial resistance. The European Union is responding to this growing problem by reducing the use of antibiotics.

FVE has adopted in the last General Assembly a position paper on the relationship between antibiotics and animal welfare.

The EC welcomes the commitment by the G20 Agriculture Ministerial meeting to support sustainable agriculture for ensuring global food security and to fight antimicrobial resistance, including the phasing out of antibiotics as growth promoters in animals.

Department of Defense notified stakeholders that had identified the first colistin-resistant mcr-1 E. coli in a person in the United States. A USDA and HHS search for colistin-resistant bacteria in food animals, retail meats and people also has found colistin-resistant E. coli in a single sample from a pig intestine.

EMA has launched a public consultation to minimise sales of colistin for use in animals and restrict its use in animals to last resort treatment only.

EFSA’s data includes compliance rates with EU residue limits, for a range of veterinary medicines, unauthorised substances and contaminants found in animals and animal-derived food.

The increasing occurrence and spread of bacterial resistance against antimicrobials reported in recent years is today considered a major risk by the international community.

The final rule also includes an additional reporting provision intended to enhance our understanding of antimicrobial new animal drug sales.